Jacob L. Van Dam - Publications

Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 01, 2026

Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 29, 2026

The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer - Authors' reply.

Journal: The Lancet. Oncology

Published: December 01, 2025

Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trials.

Journal: The British journal of surgery

Published: August 20, 2025

Prediction of resection after preoperative FOLFIRINOX in patients with localized pancreatic adenocarcinoma: a Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.

Journal: Journal of the National Cancer Institute

Published: July 22, 2025

Staging Laparoscopy After Neoadjuvant Treatment for Pancreatic Cancer to Prevent Non-Therapeutic Laparotomy: Analysis in the PREOPANC-2 Randomized Trial.

Journal: Annals of surgery

Published: June 23, 2025

Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial.

Journal: Annals of surgery

Published: April 28, 2025

Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial.

Journal: The Lancet. Oncology

Published: December 13, 2024

Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma.

Journal: JAMA surgery

Published: November 06, 2024

Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial.

Journal: Annals of surgical oncology

Published: November 05, 2024

Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.

Journal: British journal of cancer

Published: October 26, 2024

Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy.

Journal: JAMA network open

Published: June 18, 2024